Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / S&P PHARMAC
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
3,784,179
-
Shares change
-
+68,708
-
Total reported value, excl. options
-
$167,240,636
-
Value change
-
+$3,100,968
-
Put/Call ratio
-
29.7%
-
Number of buys
-
29
-
Number of sells
-
-27
-
Price
-
$44.19
Significant Holders of SPDR SERIES TRUST - S&P PHARMAC (XPH) as of Q3 2016
74 filings reported holding XPH - SPDR SERIES TRUST - S&P PHARMAC as of Q3 2016.
SPDR SERIES TRUST - S&P PHARMAC (XPH) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,784,179 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (728,609 shares), Psagot Investment House Ltd. (446,036 shares), UBS Group AG (437,030 shares), BANK OF AMERICA CORP /DE/ (432,512 shares), MORGAN STANLEY (278,591 shares), BARCLAYS PLC (200,560 shares), Wharton Business Group, LLC (193,100 shares), Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet LTD (107,450 shares), Baird Financial Group, Inc. (103,648 shares), and Hochman Cole Investment Advisors, Inc. (70,382 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.